Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.810
+0.220 (6.13%)
At close: Aug 24, 2026, 4:00 PM EDT
3.750
-0.060 (-1.57%)
After-hours: Aug 24, 2026, 6:56 PM EDT
Xenetic Biosciences Earnings Call Transcripts
Fiscal Year 2025
-
The meeting was called to order with auditors and legal counsel present, but a quorum was not reached, preventing any business from being conducted. The board will set a new date for the adjourned meeting.
Fiscal Year 2024
-
Preclinical data show DNase I enhances the efficacy of immune checkpoint inhibitors in colorectal cancer models resistant to current therapies. These results support advancing DNase I combinations into clinical development for cancers where NETs drive resistance.